Our regulators, effectively leveraging technology, are constantly moving towards higher efficiency and improved processes in our secondary trading markets. Now, we have reached a level of T+0 ...
I count myself lucky as my ‘bread and butter’, primary market research 1, has been popular with pharma for decades: informing pre- and post- launch brand strategy; tracking market progress ...